Specialties
Board Certification
|
American Board of Surgery
|
Patient Rating
Patients consistently praise Dr. Hewitt and her team for clear, thorough explanations and for taking the time to answer questions, which helps them understand diagnoses and treatment plans. Commenters emphasize her compassion, attentiveness, trauma-informed approach, and ability to make patients feel comfortable and heard. Reviewers also note professional, personable staff and express strong trust in her clinical judgment.
Generated via Patient Reviews
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Surgery
-Associate Professor (Clinical) |
|---|---|
| Academic Divisions |
Surgical Oncology
|
| Board Certification |
American Board of Surgery
|
Education history
| Fellowship | Breast Surgical Oncology - University of California, San Francisco School of Medicine | Fellow |
|---|---|---|
| Residency | General Surgery - University of Utah School of Medicine | Resident |
| Professional Medical | Medicine - Georgetown University School of Medicine | M.D. |
| Undergraduate | Biology - Johns Hopkins University | B.A. |
Selected Publications
Journal Article
- Sorensen LM, Pushkin B, Tuttle TM, Hewitt KC, Brownson KE, Price RR (2026). Mobile Screening Drives Expanded Breast Cancer Care in Mongolia. Bull Am Coll Surg, 111(6).
- Kuo MC, Sims J, Solis OK, Meszoely IM, Sweeting RS, Grau AM, Hewitt KC, Kauffmann RM, Kelley MC, McCaffrey RL (2024). Disease recurrence in patients undergoing mastectomy for ductal carcinoma in situ. Breast Cancer Res Treat.
- Sols O, Addae J, Sweeting R, Meszoely I, Grau A, Kauffmann R, Kelley M, McCaffrey R, Hewitt K (2024). Cost containment analysis of superparamagnetic iron oxide (SPIO) injection in patients with ductal carcinoma in situ. Breast Cancer Res Treat.
- Piltin MA, Norwood P, Ladores V, Mukhtar RA, Sauder CA, Golshan M, Tchou J, Rao R, Lee MC, Son J, Reyna C, Hewitt K, Kuerer H, Ahrendt G, Greenwalt I, Tseng J, Postlewait L, Howard-McNatt M, Jaskowiak N, Esserman LJ, Boughey JC, ISPY2 Locoregional Working Group (2024). Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial. Ann Surg Oncol.
- Addae JK, Sweeting RS, Meszoely IM, McCaffrey RL, Kauffmann RM, Kelley MC, Grau AM, Hewitt K (2023). Superparamagnetic iron oxide (SPIO) for axillary mapping in patients with ductal carcinoma in situ undergoing mastectomy: single-institution experience. Breast Cancer Res Treat, 204(1), 117-121.
- Boughey JC, Yu H, Dugan CL, Piltin MA, Postlewait L, Son JD, Edmiston KK, Godellas CV, Lee MC, Carr MJ, Tonneson JE, Crown A, Lancaster RB, Woriax HE, Ewing CA, Chau HS, Patterson AK, Wong JM, Alvarado MD, Yang RL, Chan TW, Sheade JB, Ahrendt GM, Larson KE, Switalla K, Tuttle TM, Tchou JC, Rao R, Tamirisa N, Singh P, Gould RE, Terando A, Sauder C, Hewitt K, Chiba A, Esserman LJ, Mukhtar RA (2023). Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial. Ann Surg Oncol, 30(11), 6401-6410.
- Hewitt KC, Miller P, Piper M, Prionas N, Son JD, Alvarado M, Esserman LJ, Wong JM, Ewing C, Mukhtar RA (2021). Positive margins after mastectomy in patients with invasive lobular carcinoma of the breast: Incidence and management strategies. Am J Surg, 223(4), 699-704.
- Son JD, Piper M, Hewitt K, Alvarado M, Esserman LJ, Ewing C, Wong JM, Mukhtar RA (2020). Oncological Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of the Breast: A 20-Year Institutional Experience. Ann Surg Oncol, 28(5), 2555-2560.
- Hewitt K, Son J, Glencer A, Borowsky AD, Cooperberg MR, Esserman LJ (2020). The Evolution of Our Understanding of the Biology of Cancer Is the Key to Avoiding Overdiagnosis and Overtreatment. Cancer Epidemiol Biomarkers Prev, 29(12), 2463-2474.
- Hewitt K, Lin H, Faraklas I, Morris S, Cochran A, Saffle J (2013). Use of methylnaltrexone to induce laxation in acutely injured patients with burns and necrotizing soft-tissue infections. J Burn Care Res, 35(2), e106-11.
- Scaife CL, Hewitt KC, Mone MC, Hansen HJ, Nelson ET, Mulvihill SJ (2013). Comparison of intraoperative versus delayed enteral feeding tube placement in patients undergoing a Whipple procedure. HPB (Oxford), 16(1), 62-9.
Letter
- Scaife CL, Hewitt K, Sheng X, Russell KW, Mone MC (2015). Reply: Should we operate for an intraabdominal emergency in the setting of disseminated cancer? [Letter to the editor]. Surgery, 159(3), 981-3.
- Scaife CL, Hewitt K, Sheng X, Russell KW, Mone MC (2015). Should we operate for an intra-abdominal emergency in the setting of disseminated cancer? [Letter to the editor]. Surgery, 158(3), 636-45.
Abstract
- Piltin MA, Norwood P, Ladores V, Mukhtar RA, Sauder CA, Golshan M, Tchou J, Rao R, Lee MC, Son J, Reyna C, Hewitt K, Kuerer H, Ahrendt G, Greenwalt I, Tseng J, Postlewait L, Howard-McNatt M, Jaskowiak N, Esserman LJ, ISPY2 Locoregional Working Group, Boughey JC (2024). ASO Visual Abstract: Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy-Results from the I-SPY2 Clinical Trial. [Abstract]. Ann Surg Oncol.
She was very informative. Helped in making my plan for treatment. Personable. Easy to trust her judgment. She showed empathy.
Dr Hewitt was very kind and open for any questions.
Great review of what was happening and possible ways of treatment
Dr Hewitt took her time to explain everything and made me very comfortable
Very very good at what she does.
Dr. Hewitt is amazing and really cares about her patients.
I love the way Dr. Hewitt took the time to fully explain the process of what I'll be going through. She was attentive and very trauma informed. She listened carefully and made sure I understood what was being explained to me. I truly appreciate her.
Professional. Plan still in progress due to testing results to be scheduled this week.
Dr. Hewitt is kind, compassionate & extremely knowledgeable. She made me feel comfortable right from the start. She wants what's best for her patients. She explains things in terminology that you can understand. I look forward to having her treat me.
She was quite wonderful and explained the difficult topics about my diagnoses clearly
Dr. Hewitt was very kind, professional and clear in communicating the best treatment in my case. It was so helpful to better understand my situation and have all questions answered in way that provided confidence. I would highly recommend her to anyone needing treatment.
Kelly did a great job !
Dr K. Hewitt and all of her nursing staff are wonderful!
She was so understanding and very thorough in her answers and explanations. My family and I like very much.
Took the time to make me comfortable .
I would recommend her to anyone needing her services. Very respectful and professional in explaining procedures that will benefit the patient in the process.